U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H10N2.ClH
Molecular Weight 230.693
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMINACRINE HYDROCHLORIDE

SMILES

Cl.NC1=C2C=CC=CC2=NC3=CC=CC=C13

InChI

InChIKey=FTGPOQQGJVJDCT-UHFFFAOYSA-N
InChI=1S/C13H10N2.ClH/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;/h1-8H,(H2,14,15);1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C13H10N2
Molecular Weight 194.2319
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/23841224

Aminacrine has long been known to be a potent frameshift mutagen in viruses and bacteria. It is one in a general class of aminoacridine dyes that bind to DNA and possess mutagenic activity. Aminacrine is used clinically as a topical antiseptic. A part from therapeutic use, aminacrine is also introduced as a matrix for negative mode matrix-assisted laser desorption/ionization (MALDI).

Approval Year

Conditions

Conditions

Doses

Doses

DosePopulationAdverse events​
14 mg 2 times / day multiple, vaginal
Recommended
Dose: 14 mg, 2 times / day
Route: vaginal
Route: multiple
Dose: 14 mg, 2 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: F
Sources:
Other AEs: Vulvovaginal discomfort...
Other AEs:
Vulvovaginal discomfort (2 patients)
Sources:
AEs

AEs

AESignificanceDosePopulation
Vulvovaginal discomfort 2 patients
14 mg 2 times / day multiple, vaginal
Recommended
Dose: 14 mg, 2 times / day
Route: vaginal
Route: multiple
Dose: 14 mg, 2 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: F
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
2010-10
Mononuclear Fe(II)-N4Py complexes in oxidative DNA cleavage: structure, activity and mechanism.
2010-09-14
MALDI-TOF/MS analysis of archaebacterial lipids in lyophilized membranes dry-mixed with 9-aminoacridine.
2010-09
Lipidomic analysis of porcine olfactory epithelial membranes and cilia.
2010-07
Mutagenic and antimutagenic effects of hexane extract of some Astragalus species grown in the eastern Anatolia region of Turkey.
2010-07
Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions.
2010-06-30
Significant sensitivity improvements by matrix optimization: a MALDI-TOF mass spectrometric study of lipids from hen egg yolk.
2010-06
Selective desorption/ionization of sulfatides by MALDI-MS facilitated using 9-aminoacridine as matrix.
2010-06
The surface charge density of plant cell membranes (sigma): an attempt to resolve conflicting values for intrinsic sigma.
2010-05
Host hindrance to HIV-1 replication in monocytes and macrophages.
2010-04-07
The intact muscle lipid composition of bulls: an investigation by MALDI-TOF MS and 31P NMR.
2010-02
Genotoxicity and antigenotoxicity evaluation of non-photoactivated hypericin.
2010-01
Investigation on the Interactions of NiCR and NiCR-2H with DNA.
2010
Alveolar osteitis: a comprehensive review of concepts and controversies.
2010
Phosphatidylcholines and -ethanolamines can be easily mistaken in phospholipid mixtures: a negative ion MALDI-TOF MS study with 9-aminoacridine as matrix and egg yolk as selected example.
2009-12
Identification of chemical compounds that induce HIF-1alpha activity.
2009-11
Binding of TCA to the prion protein: mechanism, implication for therapy, and application as probe for complex formation of bio-macromolecules.
2009-10
A kinetic and structural investigation of DNA-based asymmetric catalysis using first-generation ligands.
2009-09-21
9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.
2009-07-24
In situ primary metabolites localization on a rat brain section by chemical mass spectrometry imaging.
2009-07-01
Biological safety of LipoFullerene composed of squalane and fullerene-C60 upon mutagenesis, photocytotoxicity, and permeability into the human skin tissue.
2009-06
Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates.
2009-04-01
Biological safety of liposome-fullerene consisting of hydrogenated lecithin, glycine soja sterols, and fullerene-C60 upon photocytotoxicity and bacterial reverse mutagenicity.
2009-04
9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
2009-02-26
Blockade of NMDA receptor channels by 9-aminoacridine and its derivatives.
2009-02-13
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials.
2009-01-22
Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.
2009-01-14
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of cellular glycerophospholipids enabled by multiplexed solvent dependent analyte-matrix interactions.
2008-10-01
New palladium(II) and platinum(II) complexes with 9-aminoacridine: structures, luminiscence, theoretical calculations, and antitumor activity.
2008-08-04
Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage.
2008-05-15
Negative ion mode matrix-assisted laser desorption/ionisation time-of-flight mass spectrometric analysis of oligosaccharides using halide adducts and 9-aminoacridine matrix.
2008-04
Effect of spermine conjugation on the interaction of acridine with alternating purine-pyrimidine oligodeoxyribonucleotides studied by CD, fluorescence and absorption spectroscopies.
2008-04
Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation.
2008-03-18
Ultrasonic trapping of microparticles in suspension and reaction monitoring using Raman microspectroscopy.
2007-10-15
Modulation of the genotoxicity of bleomycin by amines through noncovalent DNA interactions and alteration of physiological conditions in yeast.
2007-10-01
The electrochemical behavior and direct determination of tyrosine at a glassy carbon electrode modified with poly (9-aminoacridine).
2007-10
A role of the 9-aminoacridines and their conjugates in a life science.
2007-10
Frameshift mutations produced by 9-aminoacridine in wild-type, uvrA and recA strains of Escherichia coli; specificity within a hotspot.
2007-09
In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
2007-08-07
Preparation of magnetite nanocrystals with surface reactive moieties by one-pot reaction.
2007-07-15
Unexpected reactivity of the 9-aminoacridine chromophore in guanidylation reactions.
2007-07-06
Molecular recognition of DNA by rigid [N]-polynorbornane-derived bifunctional intercalators: synthesis and evaluation of their binding properties.
2007-05-17
Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
2007-04
A binary matrix for background suppression in MALDI-MS of small molecules.
2007-03
A real-time fluorescence assay for measuring N-dealkylation.
2007-01
Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity.
2007
Analysis of low molecular weight acids by negative mode matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2007
Quantitative detection of metabolites using matrix-assisted laser desorption/ionization mass spectrometry with 9-aminoacridine as the matrix.
2007
Imaging Matrix Assisted Laser Desorption Ionization Mass Spectrometry: a technique to map plant metabolites within tissues at high spatial resolution.
2007
Acridin-9-yl exchange: a proposal for the action of some 9-aminoacridine drugs.
2006
Patents

Sample Use Guides

In Vivo Use Guide
Vaginal suppositories containing 1.05 g of sulfanilamide, 14 mg of aminacrine hydrochloride, and 140 mg of allantoin (AVC suppositories) were given twice a day for 7 days.
Route of Administration: Vaginal
In Vitro Use Guide
S. typhimurium cells were treated with aminacrine at concentration of 2-250 ug/ml and incubated during 60 min.
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:58:41 GMT 2025
Edited
by admin
on Mon Mar 31 17:58:41 GMT 2025
Record UNII
OR5RM3Q5QL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMINOACRIDINE HYDROCHLORIDE
MART.   WHO-DD  
Preferred Name English
AMINACRINE HYDROCHLORIDE
HSDB   MI   USAN   VANDF  
USAN  
Official Name English
Aminoacridine hydrochloride [WHO-DD]
Common Name English
AMINACRINE HYDROCHLORIDE [VANDF]
Common Name English
MONACRIN
Brand Name English
NSC-7571
Code English
AMINACRINE HYDROCHLORIDE [MI]
Common Name English
AMINACRINE HYDROCHLORIDE [USAN]
Common Name English
AMINOACRIDINE HCL
Common Name English
AMINOACRIDINE HYDROCHLORIDE [MART.]
Common Name English
9-ACRIDINAMINE MONOHYDROCHLORIDE
Systematic Name English
AMINACRINE HYDROCHLORIDE [HSDB]
Common Name English
AMINACRINE HCL
Common Name English
Classification Tree Code System Code
CFR 21 CFR 310.531
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
NCI_THESAURUS C28394
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
EPA PESTICIDE CODE 55503
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
Code System Code Type Description
EVMPD
SUB00450MIG
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
PUBCHEM
8643
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
NSC
7571
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
CAS
134-50-9
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-145-5
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
MERCK INDEX
m1672
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY Merck Index
RXCUI
81949
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY RxNorm
NCI_THESAURUS
C77024
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
SMS_ID
100000085173
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
ChEMBL
CHEMBL43184
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
FDA UNII
OR5RM3Q5QL
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID8030473
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
CHEBI
74837
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
HSDB
4505
Created by admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY